Try our Advanced Search for more refined results

ATHENEX PHARMA SOLUTIONS, LLC et al v. AZAR, II et al

  1. August 01, 2019

    FDA Limits On Vasopressin Compounding Valid, Says Judge

    A D.C. federal judge on Thursday chucked a challenge to the U.S. Food and Drug Administration's limits on drug compounding with the hormone vasopressin, rejecting assertions that the agency is improperly policing the practice of medicine.

  2. April 01, 2019

    FDA Looks To End Athenex's Active Ingredient Suit

    The U.S. Food and Drug Administration has urged a federal court to toss Athenex Inc.'s challenge to the agency's finding that there was no clinical need for a drug containing the hormone vasopressin, calling the biopharmaceutical company's claim the FDA was trying to improperly regulate the practice of medicine "frivolous." 

  3. March 19, 2019

    Athenex Says FDA Wrongly Policing Practice Of Medicine

    Athenex Inc. asked a D.C. federal judge for a quick win in its suit over the U.S. Food and Drug Administration's finding that there isn't a clinical need for a drug product containing the hormone vasopressin, arguing that the agency is improperly regulating the practice of medicine.